Novartis
NVS
#58
Rank
NZ$439.41 B
Marketcap
NZ$229.01
Share price
1.58%
Change (1 day)
37.64%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Earnings for Novartis (NVS)

Earnings in 2025 (TTM): NZ$28.27 Billion

According to Novartis's latest financial reports the company's current earnings are NZ$56.37 Billion. In 2024 the company made an earning of NZ$23.44 Billion, an increase over its 2023 earnings that were of NZ$15.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novartis from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$28.27 B20.62%
2024 NZ$23.44 B49.51%
2023 NZ$15.67 B13.48%
2022 NZ$13.81 B-69.24%
2021 NZ$44.91 B164.6%
2020 NZ$16.97 B10.49%
2019 NZ$15.36 B-36.26%
2018 NZ$24.10 B55.86%
2017 NZ$15.46 B15.12%
2016 NZ$13.43 B-3.9%
2015 NZ$13.97 B-33.72%
2014 NZ$21.08 B14.87%
2013 NZ$18.35 B-2.93%
2012 NZ$18.91 B2.15%
2011 NZ$18.51 B-7.94%
2010 NZ$20.10 B17.94%
2009 NZ$17.05 B4.45%
2008 NZ$16.32 B27.5%
2007 NZ$12.80 B-6.31%
2006 NZ$13.66 B9.46%
2005 NZ$12.48 B5.17%
2004 NZ$11.87 B13.84%
2003 NZ$10.42 B-38.51%
2002 NZ$16.95 B574.04%
2001 NZ$2.51 B83%
2000 NZ$1.37 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
NZ$39.68 B 40.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.36 B-27.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.67 B 97.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.63 B-44.57%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$16.02 B-43.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$3.04 B-89.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
NZ$13.80 B-51.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.98 B-50.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$22.49 B-20.28%๐Ÿ‡ฌ๐Ÿ‡ง UK